For treating cancer.
Brand Name(s): Anktiva
Generic Name: Nogapendekin alfa inbakicept-pmln
Instructions
This medicine is given into the bladder. DO NOT inject this medicine.
This medicine should be given by a trained health care provider.
This medicine usually stays in the bladder for 2 hours and then it is urinated out. Carefully follow the instructions from your doctor.
Avoid contact with your urine after each treatment. To avoid splashing, sit down on the toilet seat to urinate.
After using this medicine, drink fluids as directed by your doctor to help clear the medicine from the body.
It is important that you keep taking each dose of this medicine on time even if you are feeling well.
If you miss a dose, contact your doctor for instructions.
This medicine is usually combined with another medicine to treat your condition.
Drug interactions can change how medicines work or increase risk for side effects. Tell your health care providers about all medicines taken. Include prescription and over-the-counter medicines, vitamins, and herbal medicines. Speak with your doctor or pharmacist before starting or stopping any medicine.
Keep all appointments for medical exams and tests while on this medicine.
Cautions
Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine.
It is unknown if this medicine passes into breast milk. Ask your doctor before breastfeeding.
Women of childbearing age should have a negative pregnancy test before starting this medicine.
This medicine can hurt a new baby in the womb. If you become pregnant while on this medicine, tell your doctor immediately. Your doctor may switch you to a different medicine.
Women must use reliable forms of birth control while taking this medicine and for 1 week after stopping to prevent pregnancy.
Side Effects
The following is a list of some common side effects from this medicine. Please speak with your doctor about what you should do if you experience these or other side effects.
- pain and discomfort in the bladder
- lack of energy and tiredness
- fever or chills
- joint or muscle pain
- nausea
- blood in urine
- increased urinary frequency
- difficulty or discomfort urinating
A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.
Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.
IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all there is to know about it. Your doctor or pharmacist may give you other documents about your medicine. Please talk to them if you have any questions. Always follow their advice.
There is a more complete description of this medicine available in English. Scan this code on your smartphone or tablet or use the web address below. You can also ask your pharmacist for a printout. If you have any questions, please ask your pharmacist.
The display and use of this drug information is subject to Terms of Use.
More information about NOGAPENDEKIN ALFA INBAKICEPT - INTRAVESICAL
Copyright(c) 2024 First Databank, Inc.
Selected from data included with permission and copyright by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
Conditions of Use: The information in this database is intended to supplement, not substitute for the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. The display and use of this drug information is subject to express Terms of Use.